TOP STORIES

• BUSINESS ViiV Supporting Campaigns to Raise HIV Diagnosis Rate in Japan: CEO
  June 24, 2019

• REGULATORY Japan Cabinet Adopts 2019 Honebuto Policy, No Big Change Made on Drug Pricing
  June 24, 2019

• TRENDS 12 Foreign Drug Makers Eke Out 1.2% Growth in Japan, but Stagnation Lingers
  June 21, 2019

• REGULATORY MOF Panel Paper Reiterates Copay Raise for “Small-Risk” Disease Treatments
  June 20, 2019

• REGULATORY Japan Approves Roche/Chugai’s Tumor-Agnostic Rozlytrek, Alnylam’s RNAi Drug and More
  June 19, 2019

• TRENDS Foreign Pharmas Creating Environments to Empower Women, Making Headway for Sales Reps Too
  June 18, 2019

• ORGANIZATION Fix Price Maintenance Premium to Make It Fit Its Concept, Revisit Product/Company Criteria: FPMAJ
  June 17, 2019

• BUSINESS Japanese Drug Makers Beefing Up China Biz amid Regulatory Tailwind
  June 14, 2019

• REGULATORY Nesp Biosame to Join NHI Price List, Launch Due by September; Symbicort Generics, Teribone AG Skip Listing
  June 13, 2019

• BUSINESS Rakuten Medical Could File Photoimmunotherapy for Head and Neck Cancer in 2022; COO Says More Indications Eyed
  June 12, 2019

• BUSINESS Japan Ethical Drug Sales Shrivel, but Many Beat Conservative Guidance
  June 11, 2019

• REGULATORY MHLW Study Group Drafting Guidelines for New Dyslipidemia Drug Development, First in 30 Years
  June 11, 2019

• BUSINESS Pfizer Keeps Diverse Portfolio Strategy amid Sluggish Bavencio, Oncology Chief Says I/O Just One Area of Cancer Care
  June 10, 2019

• BUSINESS Royalties Push Up Profits at 3 Major Makers, Shionogi Sees 40% Operating Margin This Year
  June 7, 2019

• ORGANIZATION Doctors’ Lobby Voices Opposition to Changing Health Coverage, Copay Rates for Minor Illnesses
  June 6, 2019

• ORGANIZATION Ahead of G20 Summit, Global Pharma Leaders Prod PM Abe to Take Leadership in Addressing Health Challenges
  June 5, 2019

• REGULATORY Reborn PMDA Boots Up under New Skipper, Bolstering “Patient First” Initiatives
  June 4, 2019

• BUSINESS Biogen to Leverage Aducanumab Learnings, Spinraza to Remain Foundation of SMA Care: Japan Chief
  June 3, 2019

• REGULATORY June Approval Likely for Chugai’s NTRK-Gene Targeting Entrectinib, 2nd Tumor-Agnostic Drug
  May 31, 2019

• REGULATORY LDP Junior Politicians Set Up Vaccine Study Group
  May 31, 2019

ページ

• « 先頭
• ‹ Prev
• …
• 128
• 129
• 130
• 131
• 132
• 133
• 134
• 135
• 136
• …
• Next ›
• 最終 »